A Critical Pathway for Implantable Cardioverter-Defibrillators in Patients With Ischemic Cardiomyopathy

Not Applicable

• Conditions: Myocardial Infarction; Heart Failure
• Interventions: Other: Use of the ICD Critical Pathway

• Registration Number: NCT01248702
• Lead Sponsor: University of British Columbia

Brief Summary

The purpose of this study is to develop and implement a critical pathway to identify patients with ischemic cardiomyopathy who are candidates for an implantable cardioverter-defibrillator (ICD). This study will also determine whether the use of the critical pathway for ICDs is associated with a change in the ICD referral and implantation rate.

Detailed Description

Despite improvements in both medical management and revascularization strategies, sudden death is still a significant complication in patients with ischemic cardiomyopathy. There is strong evidence to support the role of ICDs for the primary prevention of sudden death in this population. However, in Canada and the United States, ICDs are underutilized.

Critical pathways are algorithms that improve health care delivery and clinical outcomes while reducing practice variability. The use of a critical pathway to assess a patient's eligibility for an ICD may increase the appropriate use of this evidence-based technology.

Study Timeline

• Study First Submitted: 2010-11-22
• Study First Submitted QC: 2010-11-23
• Study First Posted: 2010-11-25
• Status Verified: 2012-03
• Last Update Submitted: 2012-03-06
• Last Update Posted: 2012-03-07
• Study Start: 2012-04
• Primary Completion: 2012-05
• Study Completion: 2012-05

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

• acute ST segment elevation myocardial infarction (STEMI)
• candidate for percutaneous revascularization
• permanent residents of British Columbia, Canada

Read More

Exclusion Criteria

• patients with heart disease or a comorbid illness who have a documented life expectancy of less than 1 year

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Critical Pathway	Use of the ICD Critical Pathway	-

Primary Outcome Measures

Name	Time	Method
Rate of Referral for ICD Assessment	1 year

Secondary Outcome Measures

Name	Time	Method
Rate of ICD Implantation	1 year

Trial Locations

Locations (1)

St. Paul's Hospital; 🇨🇦 Vancouver, British Columbia, Canada